Sector consensus Amplia Therapeutics Limited

Stocks

Market Closed - Australian S.E. 02:10:26 2026-09-18 EDT			5-day change	1st Jan Change
0.1250 ^AUD	0.00%		+4.17%	-16.67%

09-14	Amplia Therapeutics, ANZGOG Finalize Protocol for Phase Two Ovarian Cancer Trial; Shares Up 4%	MT
08-03	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
AMPLIA THERAPEUTICS LIMITED	-	-	0.42	+236%	1
WUXI APPTEC CO., LTD.			187.07	+16.56%	18
ARGENX SE			1,178.77	+18.28%	15
INSMED INCORPORATED			199.55	+60.95%	22
BIONTECH SE			102.91	+20.37%	20
GENMAB A/S			2,453.79	+9.35%	15
PHARMAESSENTIA CORPORATION			1,397.26	+16.93%	8
EXELIXIS, INC.			53.69	-8.21%	16
SUMMIT THERAPEUTICS INC.			21.57	+64.19%	13
MADRIGAL PHARMACEUTICALS, INC.			678.06	+26.88%	16
CYTOKINETICS, INCORPORATED			109.9	+57.18%	20
ARROWHEAD PHARMACEUTICALS, INC.			110	+62.39%	12
VAXCYTE, INC.			109	+80.55%	9
IMMUNITYBIO, INC.			12.75	+50.71%	4
SPYRE THERAPEUTICS, INC.			120.08	+29.56%	13
BELITE BIO, INC			228.89	+34.36%	9
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	-	-	-	-	-
BIOCON LIMITED			446.89	+17.6%	19
ORUKA THERAPEUTICS, INC.			155	+58.6%	12
SCHOLAR ROCK HOLDING CORPORATION			69.94	+42.67%	16
Average			401.87	+47.10%	14
Weighted average by Cap.			559.2	+28.83%	16